
Nuritas raises $42m Series C to boost market penetration
Nuritas’ Series C round fuels ingredient innovation and market penetration

Nuritas’ Series C round fuels ingredient innovation and market penetration

There are complicated books about the business world. Michael Bush, founder of advisory firm GrowthWays Partners, said the one he wrote was not intended to be.

As we gear up for the 2025 NutraIngredients Awards, we are excited to introduce the distinguished panel of judges who will evaluate and honor the most innovative and impactful achievements in the industry.

Catch up with our weekly round-up of key news from across the Nutraverse.

After another year speaking to leading experts, digging into the latest science, discovering exciting insights, and delivering the latest scoop, the editorial team at NutraIngredients reminisces over its 2024 highlights.

We reveal the top 10 most-read news articles featuring NutraIngredients-Asia’s interviews with functional ingredients suppliers in the past year.

Human milk oligosaccharides (HMOs) could potentially support neurological function, immune and metabolic health, offering a unique differentiation against existing prebiotic formulations in the market.